Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial

Monitoring ctDNA can predict relapse after CAR-T for DLBCL, especially when post treatment PET may be unequivocal.

Read the full article here

Related Articles